NSC95397 Is a Novel HIV-1 Latency-Reversing Agent

Randilea Nichols Doyle(University of California, Los Angeles), Oliver I. Fregoso(University of California, Los Angeles)
Viruses
November 16, 2024
Cited by 2


Related Papers

NSC95397 is a Novel HIV-1 Latency Reversing Agent
|bioRxiv (Cold Spring Harbor Laboratory)|2023|2